Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas

Published:2009-09 Issue:3 Volume:92 Page:405-410
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Zips Daniel,Le Katja,Yaromina Ala,Dörfler Annegret,Eicheler Wolfgang,Zhou Xuanjing,Geyer Peter,Hilberg Frank,Baumann Michael

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference42 articles.

1. Targeting the tumor blood vessel network to enhance the efficacy of radiation therapy;Siemann;Semin Radiat Oncol,2003

2. Clinical radiobiology in 2008;Begg;Radiother Oncol,2008

3. Tumour vascularization: sprouting angiogenesis and beyond;Hillen;Cancer Metastasis Rev,2007

4. BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy;Hilberg;Cancer Res,2008

5. Exploring the role of cancer stem cells in radioresistance;Baumann;Nat Rev Cancer,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation;Clinical and Translational Radiation Oncology;2022-03

2. Simultaneous PLK1 inhibition improves local tumour control after fractionated irradiation;Radiotherapy and Oncology;2013-09

3. Ablative Hypofractionated Radiotherapy Normalizes Tumor Vasculature in Lewis Lung Carcinoma Mice Model;Radiation Research;2013-04

4. Molecular Profiling to Optimize Treatment in Non-Small Cell Lung Cancer: A Review of Potential Molecular Targets for Radiation Therapy by the Translational Research Program of the Radiation Therapy Oncology Group;International Journal of Radiation Oncology*Biology*Physics;2012-07

5. Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer;Cancer Research and Treatment;2012-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3